What You Should Know:
– Rimidi, a digital health company that supports healthcare providers with EHR-integrated software and connected devices, has announced its participation in the Health Care by Food (GoFreshSoutheast) Trial. The trial is managed by Beth Israel Deaconess Medical Center (BIDMC) and funded by The American Heart Association.
– The goal of the trial is to evaluate the impact of DASH-aligned grocery store delivery in reducing high blood pressure in adults.
– The trial is part of the American Heart Association’s “food is medicine” initiative, which is a coordinated effort to integrate healthy food into healthcare as a tool to treat, manage, and prevent diet-related diseases.
A Study on the Impact of DASH-Aligned Groceries
The GoFresh Southeast trial will enroll adults aged 18 and older who live in Georgia, Florida, or Tennessee and have a history of elevated blood pressure or hypertension. Participants will be randomly assigned to one of two groups for one month: a group that receives DASH-aligned groceries delivered to their home with the assistance of a registered dietitian, and a group that receives a stipend for self-directed grocery shopping. Both groups will also be given a cellularly-enabled blood pressure cuff to monitor their progress.
During the trial, BIDMC will leverage Rimidi’s Remote Patient Monitoring (RPM) platform to support study enrollment, as well as track and report data from the connected blood pressure cuffs. The ultimate goal is to improve hypertension management and achieve better blood pressure control through proactive, data-driven insights.
Validating Dietary Interventions with Remote Monitoring
Nearly half of all adults in the U.S. have hypertension, which is one of the most important modifiable risk factors for cardiovascular disease. Remote monitoring helps both patients and clinicians by enabling timely interventions and improving management.
“We’ve always known the DASH diet is effective, but now, with remote monitoring, we’ll be able to see its real-time impact on blood pressure”, said Lucienne Ide, MD, PhD, CEO and Founder of Rimidi. “This study will be an excellent example of how technology can give us a deeper understanding of how dietary interventions work outside of a clinical setting.”
